AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,734,000 | +41.5% | 78,611 | +7.5% | 0.01% | +25.0% |
| Q4 2018 | $2,639,000 | -69.8% | 73,096 | -48.5% | 0.00% | -20.0% |
| Q3 2018 | $8,732,000 | +84.2% | 141,874 | +102.2% | 0.01% | -16.7% |
| Q2 2018 | $4,740,000 | -53.6% | 70,165 | -62.7% | 0.01% | -53.8% |
| Q1 2018 | $10,212,000 | -4.3% | 188,232 | +5.4% | 0.01% | -7.1% |
| Q4 2017 | $10,676,000 | +25.4% | 178,670 | +2.0% | 0.01% | +16.7% |
| Q3 2017 | $8,513,000 | -6.7% | 175,157 | +0.9% | 0.01% | -7.7% |
| Q2 2017 | $9,125,000 | +304.7% | 173,647 | +249.2% | 0.01% | +333.3% |
| Q1 2017 | $2,255,000 | +25.9% | 49,726 | +5.1% | 0.00% | 0.0% |
| Q4 2016 | $1,791,000 | +24.2% | 47,324 | +23.9% | 0.00% | +50.0% |
| Q3 2016 | $1,442,000 | +114.6% | 38,197 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $672,000 | +75.5% | 38,197 | +21.4% | 0.00% | 0.0% |
| Q1 2016 | $383,000 | -50.0% | 31,461 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $766,000 | +37.3% | 31,461 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $558,000 | +0.5% | 31,461 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $555,000 | +15.4% | 31,461 | +104.9% | 0.00% | 0.0% |
| Q1 2015 | $481,000 | +7.4% | 15,358 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $448,000 | +40.9% | 15,358 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $318,000 | -16.3% | 15,358 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $380,000 | +45.0% | 15,358 | +24.1% | 0.00% | 0.0% |
| Q1 2014 | $262,000 | +91.2% | 12,380 | +62.0% | 0.00% | – |
| Q4 2013 | $137,000 | – | 7,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|